Gender-affirming care

Terms

GAHT

Gender-affirming hormone therapy

VTE

Venous thromboembolism (blood clots)

• Gender-affirming care reduced depression by 60% and suicidality by 73% of trans adolescents in just one year¹.
• The longest study involving trans and nonbinary youth showed reduction in depression and anxiety.²
• Gender affirmation is linked to improved mental health. There’s no evidence it drives youth suicide.³
• Social interventions have been found to lower the rates of depression and anxiety in trans and nonbinary children⁴.
• Long-term data suggests that gender-affirming hormone therapy has no negative effect on bone⁵⁶.
• Youth on puberty blockers overwhelmingly chose to start gender-affirming hormones⁶.
• Current limited evidence suggest that transgender women taking GAHT have increased risks of ischemic stroke and VTE, with the incidence rate (per year) increasing from 0.07% to 0.13% and 0.07% to 0.32%, respectively, compared to cisgender men, and these risk factors should be adequately managed⁷.
• A review of 27 studies involving almost 8,000 teens and adults who had transgender surgeries, mostly in Europe, the U.S. and Canada, found that on average 1% expressed regret.⁸ Another study of 1,989 individuals found that 6 patients (0.3%) requested reversal surgery during the course of 14 months⁹.

References

---